Schlesinger N, Norquist JM, Watson DJ. Serum urate during acute gout. J Rheumatol 2009;36:1287–9. In the Results section, page 1288, the third paragraph should read as follows. We regret the error.
“A SU ≤ 8 mg/dl was observed in 32% (n = 109) [not n = 102] of patients overall, including 49% (n = 27) of patients taking allopurinol versus 29% (n = 82) of those not taking allopurinol (p < 0.0001) (Table 2). A SU ≤ 6 mg/dl was observed in 14% (n = 48) [not 11% (n = 32)] of patients overall, including 29% (n = 16) of patients taking allopurinol versus 11% (n = 32) of those not taking allopurinol.”